AggiornAmenti in riAnimAzione e terApiA intensivA - Pacini Editore
AggiornAmenti in riAnimAzione e terApiA intensivA - Pacini Editore
AggiornAmenti in riAnimAzione e terApiA intensivA - Pacini Editore
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
28<br />
impaired microvascular perfusion <strong>in</strong> sepsis requires<br />
activated coagulation and p-select<strong>in</strong>-mediated<br />
platelet adhesion <strong>in</strong> capillaries<br />
F. Li<br />
C.G. Ellis<br />
M.D. Sharpe<br />
P.L. Gross<br />
J.X. Wilson<br />
K. Tyml<br />
Critical Illness Research,<br />
Victoria Research<br />
Laboratories, Lawson Health<br />
Research Institute, London,<br />
ON, Canada<br />
PURPOSE: Impaired microvascular perfusion <strong>in</strong> sepsis is not treated effectively<br />
because its mechanism is unknown. S<strong>in</strong>ce <strong>in</strong>flammatory and coagulation<br />
pathways cross-activate, we tested if stoppage of blood flow<br />
<strong>in</strong> septic capillaries is due to oxidant-dependent adhesion of platelets <strong>in</strong><br />
these microvessels.<br />
METhOdS: Sepsis was <strong>in</strong>duced <strong>in</strong> wild type, eNOS(-/-), iNOS(-/-), and gp91phox(-/-)<br />
mice (n = 14-199) by <strong>in</strong>jection of feces <strong>in</strong>to the peritoneum.<br />
Platelet adhesion, fibr<strong>in</strong> deposition, and blood flow stoppage <strong>in</strong> capillaries<br />
of h<strong>in</strong>dlimb skeletal muscle were assessed by <strong>in</strong>travital microscopy.<br />
Prophylactic treatments at the onset of sepsis were <strong>in</strong>travenous <strong>in</strong>jection<br />
of platelet-deplet<strong>in</strong>g antibody, P-select<strong>in</strong> block<strong>in</strong>g antibody, ascorbate,<br />
or antithromb<strong>in</strong>. Therapeutic treatments (delayed until 6 h) were <strong>in</strong>jection<br />
of ascorbate or the glycoprote<strong>in</strong> IIb/IIIa <strong>in</strong>hibitor eptifibatide, or local<br />
superfusion of the muscle with NOS cofactor tetrahydrobiopter<strong>in</strong> or NO<br />
donor S-nitroso-N-acetylpenicillam<strong>in</strong>e (SNAP).<br />
RESULTS: Sepsis at 6-7 h markedly <strong>in</strong>creased the number of stopped-flow<br />
capillaries and the occurrence of platelet adhesion and fibr<strong>in</strong> deposition<br />
<strong>in</strong> these capillaries. Platelet depletion, iNOS and gp91phox deficiencies,<br />
P-select<strong>in</strong> blockade, antithromb<strong>in</strong>, or prophylactic ascorbate prevented,<br />
whereas delayed ascorbate, eptifibatide, tetrahydrobiopter<strong>in</strong>, or SNAP<br />
reversed, septic platelet adhesion and/or flow stoppage. The reversals by<br />
ascorbate and tetrahydrobiopter<strong>in</strong> were absent <strong>in</strong> eNOS(-/-) mice. Platelet<br />
adhesion predicted 90% of capillary flow stoppage.<br />
COnCLUSIOn: Impaired perfusion and/or platelet adhesion <strong>in</strong> septic capillaries<br />
requires NADPH oxidase, iNOS, P-select<strong>in</strong>, and activated coagulation,<br />
and is <strong>in</strong>hibited by <strong>in</strong>travenous adm<strong>in</strong>istration of ascorbate and by<br />
local superfusion of tetrahydrobiopter<strong>in</strong> and NO. Reversal of flow stoppage<br />
by ascorbate and tetrahydrobiopter<strong>in</strong> may depend on local eNOSderived<br />
NO which dislodges platelets from the capillary wall.<br />
Intensive Care Med 2010;36(11):1928-34